Psychedelics News

Press Releases from Psychedelics Companies

Newsroom

Psychedelics news releases from psychedelics companies published by Newsfile. Searches will return results from stories up to two years old.

Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor
Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-02 8:12 AM EDT | Red Light Holland Corp.
HealingMaps and Advanced Behavioral Strategies Launch Healing Health Alliance, the First Group Purchasing Organization (GPO) Exclusively for Ketamine, Psychedelic Medicine and TMS Clinics
Miami, Florida--(Newsfile Corp. - July 1, 2025) - HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and TMS clinics, and Advanced Behavioral Strategies (ABS), a JV between HealingMaps and Capstone Management Group, today announced the official launch of the Healing Health Alliance, the first-of-its-kind Group Purchasing Organization (GPO) dedicated...
Multimedia/Internet/Online Services, Publishing/Informational Services, Health, Psychedelics
2025-07-01 9:00 AM EDT | HealingMaps Inc.
Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study
Toronto, Ontario--(Newsfile Corp. - June 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-06-19 8:05 AM EDT | Red Light Holland Corp.
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Denver, Colorado--(Newsfile Corp. - June 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that Psychedelic Science 2025 ("PS2025") - the world's largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture, hosted by the Multidisciplinary Associ
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-18 8:30 AM EDT | Psyence Biomedical Ltd.
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasdaq Hearings Panel confirming that the Company has regained compliance with all applicable Nasdaq continued listing requirements. This confirmation follows...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-17 8:00 AM EDT | Psyence Biomedical Ltd.
PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors
Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that Rob Steen has resigned as...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-06-16 9:04 AM EDT | PharmaDrug Inc.
Aion Therapeutic Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company's audit committee and board of directors approved a change in the Company's auditors from DNTW Toronto LLP (the "Former Auditor") to Horizon Assurance LLP (the "Successor Auditor"),...
Cannabis, Psychedelics, Cannabis Extractor, Cannabis Ancillary Service Provider
2025-06-06 5:38 PM EDT | Aion Therapeutic Inc.
PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that the board of directors ("the...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-06-06 8:00 AM EDT | PharmaDrug Inc.
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-06 7:30 AM EDT | Neural Therapeutics Inc.
Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo," or the "Company") is pleased to announce a proposed name change to "Born Defense" and a change of business to become an investment issuer focused on the defense and national security space guided...
Health, Psychedelics
2025-06-02 6:11 AM EDT | Silo Wellness Inc.
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, a leading German CBD retailer,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-28 1:52 PM EDT | Neural Therapeutics Inc.
Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies for unmet mental health needs, today announced the finalization of its service agreement with Southern Star Research Pty Ltd ("Southern Star Research"), an award-winning,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-27 7:30 AM EDT | Psyence Biomedical Ltd.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import Permit.Following this major milestone approval, Red Light Holland will ship their carefully packaged raw psilocybin truffles...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-21 8:18 AM EDT | Red Light Holland Corp.
Neural Therapeutics Announces RSU and Options Grant
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-13 4:31 PM EDT | Neural Therapeutics Inc.
Red Light Holland Announces Happy Caps 2kg "Mega Block" Mushroom Home Grow Kits Are Now Available in Costco Stores Across Canada
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a leader in functional mushrooms and home grow kits across North America and Europe, is pleased to announce that its wholly owned subsidiary, 4316747 Nova Scotia...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-13 7:30 AM EDT | Red Light Holland Corp.
Red Light Holland's Wholly Owned Subsidiary Happy Caps Launches Presales of Health Canada Approved Functional Mushroom Gummies
Toronto, Ontario--(Newsfile Corp. - May 12, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-12 7:30 AM EDT | Red Light Holland Corp.
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-09 8:26 AM EDT | Neural Therapeutics Inc.
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade MDMA and natural psilocybin, has completed its largest international export to date of MDMA capsules to Australia, supporting the treatment...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-08 7:00 AM EDT | Optimi Health Corp.
Telescope Innovations Ships First Samples of Battery-Grade Lithium Sulfide
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, today announced a key milestone in the commercial advancement of its lithium sulfide (Li₂S) production...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-05-07 8:00 AM EDT | Telescope Innovations Corp.
Optimi Health Obtains U.S. FDA Drug Establishment Registration
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin, has received its U.S. FDA Establishment Identifier (FEI) number—a key regulatory step for engaging in FDA filings and compliant supply into...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-05 7:35 AM EDT | Optimi Health Corp.

Have you heard? TMX Group has acquired Newsfile

Psychedelics News

Press Releases from Psychedelics Companies

Newsroom

RSS Feeds

Tell your psychedelics story, report your results

Cookie Settings

Have you heard? TMX Group has acquired Newsfile

Tell your psychedelics story, report your results